Detalhe da pesquisa
1.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
; 72(3): 759-767, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976415
2.
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.
J Urol
; 206(2): 240-251, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835866
3.
Symptom monitoring in cancer and fully automated advice on supportive care: Patients' perspectives on self-management strategies and the eHealth self-management application Oncokompas.
Eur J Cancer Care (Engl)
; 30(6): e13497, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339081
4.
No prime time yet for checkpoint inhibitors in localised head and neck squamous cell carcinoma.
Lancet Oncol
; 25(5): 533-534, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697152
5.
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
BMC Cancer
; 19(1): 1066, 2019 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703649
6.
Chemoradiotherapy plus a SMAC mimetic for locally advanced squamous cell carcinoma of the head and neck.
Lancet Oncol
; 21(9): 1126-1128, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758456
7.
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
Nat Commun
; 15(1): 1349, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355607
8.
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.
PLoS One
; 18(11): e0294147, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011186
9.
More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 14(5)2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267467
10.
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study.
Int Urol Nephrol
; 54(12): 3145-3152, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997906
11.
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(17): 3709-3719, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699623
12.
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
Mol Oncol
; 16(10): 2086-2097, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35181986
13.
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.
Eur Urol
; 82(5): 518-526, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933242
14.
89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer.
J Nucl Med
; 63(10): 1523-1530, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512998
15.
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells.
Clin Cancer Res
; 28(1): 215-226, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615720
16.
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
Eur Urol
; 81(4): 331-336, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086719
17.
Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer.
Oral Oncol
; 109: 104851, 2020 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32585557
18.
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
J Nucl Med
; 61(9): 1320-1325, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924729
19.
Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
Front Oncol
; 10: 761, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32582534
20.
Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid Tumors.
J Clin Oncol
; 37(5): 411-418, 2019 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586316